ISSUE: 2003/02/a To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine. After viewing the abstract use your browser's [Back] button to return to this page.

Contents

References: Clinical / Prognostic Markers

References: Basic Science / Neuroblastoma Research

References: Neurobiology / Cell Physiology Research   (neuroblastoma cell lines)

Previous Issue of Recent Publications (2003/01/a)

Back to NBL-PROF Home Page

Clinical / Prognostic Markers

Cheung NK, Kushner BH. Risks outweighed benefits from local radiation for non-stage 4 neuroblastom Int J Radiat Oncol Biol Phys 2002 Dec 1;54(5):1575; [Comment Letter]    [Related articles]

Christein JD, et al. Central pancreatectomy for a pancreatic ganglioneuroma in a patient with previous neuroblastoma. Pancreatology 2002;2(6):557-60    [Related articles]

Emir S, et al. Treatment of the neuroblastoma-associated opsoclonus-myoclonus-ataxia (OMA) syndrome with high-dose methylprednisolone. Med Pediatr Oncol 2003 Feb;40(2):139    [Related articles]

Honjo S, et al. Neuroblastoma trends in Osaka, Japan, and Great Britain 1970-1994, in relation to screening. Int J Cancer 2003 Feb 1;103(4):538-43    [Related articles]     Screening

Labdenne P, et al. Clinical use of tumor markers in childhood malignancies. Ann Med 2002;34(5):316-23    [Related articles]

Mazumdar A, et al. Whole-body fast inversion recovery MR imaging of small cell neoplasms in pediatric patients: a pilot study. AJR Am J Roentgenol 2002 Nov;179(5):1261-6    [Related articles]

Meyer JS, et al. Imaging of neuroblastoma and Wilms' tumor. Magn Reson Imaging Clin N Am 2002;10(2):275-302    [Related articles]

Pranzatelli MR, et al. Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia. Pediatr Neurol 2002 Nov;27(5):384-7    [Related articles]     Screening

Surico G, et al. New paclitaxel-cisplatin based chemotherapy regimen for advanced stage, recurrent, or refractory neuroblastoma-preliminary report. Med Pediatr Oncol 2003 Feb;40(2):130-2    [Related articles]

Warzynski MJ, et al. Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patients. Cytometry 2002 Dec 15;50(6):298-304    [Related articles]

Wong M, et al. Hip pain and childhood malignancy. Hong Kong Med J 2002 Dec;8(6):461-3    [Related articles]

Basic Science / Neuroblastoma Research

Axelrad JC, et al. The effects of acute pesticide exposure on neuroblastoma cells chronically exposed to diazinon. Toxicology 2003 Mar 14;185(1-2):67-78    [Related articles]

Berwanger B, et al. Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. Cancer Cell 2002 Nov;2(5):377-86    [Related articles]

Bierau J, et al. Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity. Int J Cancer 2003 Jan 20;103(3):387-92    [Related articles]

Chi SN, et al. Expression of SSX-2 and SSX-4 genes in neuroblastoma. Int J Biol Markers 2002 Oct-Dec;17(4):219-23    [Related articles]

Corrias MV, et al. A novel syngeneic murine model for thoracic neuroblastoma obtained by intramediastinal injection of tumor cells. Cancer Detect Prev 2002;26(6):468-75    [Related articles]

Deng W, et al. A new method for improving metaphase chromosome spreading. Cytometry 2003 Jan;51A(1):46-51    [Related articles]

Fukuzawa M, et al. Expression of vascular endothelial growth factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization. J Pediatr Surg 2002 Dec;37(12):1747-50    [Related articles]

Ho R, et al. Resistance to chemotherapy mediated by TrkB in neuroblastomas. Cancer Res 2002 Nov 15;62(22):6462-6    [Related articles]

Jaboin J, et al. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway. Cancer Res 2002 Nov 15;62(22):6756-63    [Related articles]

Maris JM, et al. Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13. Cancer Res 2002 Nov 15;62(22):6651-8    [Related articles]

Murata H, et al. Von Hippel-Lindau tumor suppressor protein transforms human neuroblastoma cells into functional neuron-like cells. Cancer Res 2002 Dec 1;62(23):7004-11    [Related articles]

Parareda A, et al. New splicing variants for human Tyrosine Hydroxylase gene with possible implications for the detection of minimal residual disease in patients with neuroblastoma. Neurosci Lett 2003 Jan 9;336(1):29-32    [Related articles]

Pende D, et al. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell Cancer Res 2002 Nov 1;62(21):6178-86    [Related articles]

Qiu YY, et al. Differential expression of DNA-methyltransferases in drug resistant murine neuroblastoma cells. Cancer Detect Prev 2002;26(6):444-53    [Related articles]

Sebastia J, et al. Evaluation of fluorescent dyes for measuring intracellular glutathione content in primary cultures of human neurons and neuroblastoma SH-SY5Y. Cytometry 2003 Jan;51A(1):16-25    [Related articles]

Spengler BA, et al. A corrected karyotype for the SH-SY5Y human neuroblastoma cell line. Cancer Genet Cytogenet 2002 Oct 15;138(2):177-8    [Related articles]

Teitz T, et al. Reply to "Expression and methylation of CASP8 in neuroblastoma: Identification of a promoter region". Nat Med 2002 Dec;8(12):1335    [Related articles]

Valent A, et al. MYCN gene overrepresentation detected in primary neuroblastoma tumour cells without amplification. J Pathol 2002 Dec;198(4):495-501    [Related articles]     MYCN Amplification

Yan P, et al. Hypermethylation-mediated regulation of CD44 gene expression in human neuroblastoma. Genes Chromosomes Cancer 2003 Feb;36(2):129-38    [Related articles]

Neurobiology / Cell Physiology Research   (neuroblastoma cell lines)

Budhram-Mahadeo V, et al. The Brn-3a POU family transcription factor stimulates p53 gene expression in human and mouse tumour cells. Neurosci Lett 2002 Dec 6;334(1):1-4    [Related articles]

Erlejman AG, et al. The oxidant defense system in human neuroblastoma IMR-32 cells predifferentiation and postdifferentiation to neuronal phenotypes. Neurochem Res 2002 Nov;27(11):1499-506    [Related articles]

Garnham BM, et al. Activation of phospholipases A2 and D of a human neuroblastoma cell line (LA-N-2) by N-dodecyl-L-lysine amide (compound 24), a putative G protein activator: characteristics of inhibition by (-)-nicotine. Neurochem Res 2002 Dec;27(12):1613-8    [Related articles]

Kaltschmidt B, et al. Cyclooxygenase-2 is a neuronal target gene of NF-kappaB. BMC Mol Biol 2002 Dec 4;3(1):16    [Related articles]

Lee G, et al. Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival. J Neurochem 2002 Oct;83(2):346-52    [Related articles]

Maccarrone M, et al. Cholesterol-dependent modulation of the toxicity of HIV-1 coat protein gp120 in human neuroblastoma cells. J Neurochem 2002 Sep;82(6):1444-52    [Related articles]

Neff F, et al. Signaling Pathways Mediate the Neuroprotective Effects of GDNF. Ann N Y Acad Sci 2002 Nov;973:70-4    [Related articles]

Pizzi M, et al. Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line. Eur J Neurosci 2002 Dec;16(12):2342-50    [Related articles]

Stephans SE, et al. Acute mitochondrial and chronic toxicological effects of 1-methyl-4-phenylpyridinium in human neuroblastoma cells. Neurotoxicology 2002 Oct;23(4-5):569-80    [Related articles]

Tokugawa K, et al. XIB4035, a novel nonpeptidyl small molecule agonist for GFRalpha-1. Neurochem Int 2003 Jan;42(1):81-6    [Related articles]

Previous Issue of Recent Publications (2003/01/a)
Back to NBL-PROF Home Page